Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year, following a 35-year career in ophthalmology.
Frinzi previously led Abbott Medical Optics, including its cataract lens replacement, laser refractive surgery and consumer eye health businesses, before they were acquired by J&J for $4.325 billion in 2016.
He has been succeeded by Warren Foust, who most recently served as worldwide president of J&J’s aesthetics and plastic surgery company, Mentor, a standalone unit housed within the conglomerate’s Ethicon medical devices division. Foust was also a member of J&J’s Cardiovascular and Specialty Services Leadership Team.
“When thinking about who would be the next leader of the surgical vision business, I knew we needed a leader with a track record of success in leading global healthcare businesses, a people-centered leadership style, a keen appreciation for the customer experience, and a high touch approach to seeking customer partnership and input,” said Frinzi, who before joining Abbott, served as president and CEO of WaveTec Vision and held a variety of roles at Bausch & Lomb Surgical, Refractec and J&J.
“Warren Foust exemplifies all of these traits, he’s a beloved leader at Johnson & Johnson, and this organization is in great hands with Warren at the helm,” he added.
Foust first joined J&J in 2011, through its acquisition of the orthopedics manufacturer Synthes. There he spent more than a decade in roles spanning trauma, joint reconstruction and craniofacial devices, as well as capital power equipment. Before that, he spent time pharmaceutical sales with Roche and Aventis.
“My priority on my first few days on the job will be to engage, listen and learn from our employees, our customers and our industry stakeholders,” Foust said in a statement. “I’ll be visiting every region in my first 100 days on the job, connecting directly with the ophthalmology community at industry events, customer meetings and Johnson & Johnson Vision’s annual kick-off meetings across APAC, EMEA and North and South America.”
Original Article: (https://www.fiercebiotech.com/medtech/j-j-vision-names-new-president-its-global-surgery-division)